Molecular mechanisms of antithrombin deficiency in two Chinese families

Thrombosis and Haemostasis

Volumn 94, Issue 6, 2005, Pages 1172-1176

  Zhou, Rong Fu ^a,b   Fu, Qi Hua ^c   Wang, Wen Bin ^a   Xie, Shuang ^a   Dai, Jin ^a   Ding, Qiu Lan ^a   Wang, Xue Feng ^a   Wang, Hong Li ^a   Wang, Zhen Yi ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c BLOOD CENTER OF ZHEJIANG PROVINCE   (China)

Author keywords

Antithrombin deficiency; Gene mutation; Venous thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ALLELE; ANIMAL CELL; ANTITHROMBIN DEFICIENCY; ARTICLE; CASE REPORT; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR MECHANICS; MUTAGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ANIMALS; ANTITHROMBINS; BLOOD COAGULATION DISORDERS, INHERITED; CERCOPITHECUS AETHIOPS; CHINA; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; GENOTYPE; HETEROZYGOTE; HUMANS; PEDIGREE; PHENOTYPE; POINT MUTATION; RNA, MESSENGER; TRANSFECTION; VENOUS THROMBOSIS;

EID: 29244450448     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-06-0450     Document Type: Article

References (16)

1. Lane DA, Bayston T, Olds RJ et al. Antithrombin mutation database: 2nd (1997) update. Thromb Haemost 1997; 77: 197-211.
2. Olds RJ, Lane DA, Chowdhury V et al. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32: 4216-24.
3. Chandra T, Stackhouse R, Kidd VJ et al. Isolation and sequence characterization of a cDNA clone of human antithrombin III. Proc Natl Acad Sci USA 1983; 80: 1845-8.
4. Qihua F, Xinguo X, Qiulan D et al. Type I antithrombin deficiency due to 13389G deletion in antithrombin gene. Chin J Hematol 2002; 23: 588-90.
5. Wen-Bin W, Qi-Hua F, Qiu-Lan D et al. Characterization of molecular defect of 13387-9delG mutated antithrombin in inherited type I antithrombin deficiency. Blood Coagul Fibrinolysis 2005; 16: 149-55.
6. Colosimo A, Xu Z, Novelli G et al. Simple version of "megaprimer" PCR for site-directed mutagenesis. Biotechniques 1999; 26: 870-3.
7. Lane DA, Olds RJ, Conard J et al. Pleiotropic effects of antithrombin strand 1C substitution mutations. J Clin Invest 1992; 90: 2422-33.
8. Tokunaga F, Shirotani H, Hara K et al. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors. FEBS Lett 1997; 412: 65-9.
9. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-30.
10. Shirotani H, Tokunaga F, Koide T. Cellular and functional characterization of three recombinant antithrombin mutants that caused pleiotropic effect-type deficiency. J Biochem 1999; 125: 253-62.
11. Nagaizumi K, Inaba H, Amano K et al. Five novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis. Int J Hematol 2003; 78: 79-83.
12. Sheffield WP, Castillo JE, Blajchman MA. Intracellular events determine the fate of antithrombin Utah. Blood 1995; 86: 3461-7.
13. Skinner R, Abrahams JP, Whisstock JC et al. The 2.6 Å structure of antithrombin indicates a conformational change at the heparin binding site. J Mol Biol 1997; 266: 601-9.
14. Jin L, Abrahams JP, Skinner R et al. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA 1997; 94: 14683-8.
15. Mille B, Watton J, Barrowcliffe TW et al. Role of N- and C-terminal animo acids in antithrombin binding to pentasaccharide. J Biol Chem 1994; 269: 29435-43.
16. Verpy E,Couture-Tosi E, Eldering E et al. Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. J Clin Invest 1995; 95: 350-9.